58 mins ago
Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy
What's happening
SignalsMonitor is following this as a health story. ScienceDaily Top News and ScienceDaily Health are the outlets attached to this story. The first report grouped here was at 13 Nov 2026, 12:48 UTC. 2 material updates are listed in the timeline. The headline in use is “Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
A study of more than 750,000 pregnancies found that early exposure to Ozempic, Wegovy, and similar drugs was not linked to increased pregnancy complications when used for weight loss, but was associated with a higher risk of premature birth when prescribed for diabetes. The surprising difference suggests that diabetes itself…
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by ScienceDaily Health
Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy
- Picked up by ScienceDaily Top News
Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy
Same story, different outlets
2 headlinesEach line is that outlet's headline. The article stays on the publisher's site.
- ScienceDaily HealthStudy of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy
- ScienceDaily Top NewsStudy of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy